JUNSJupiter Neurosciences Inc. Common Stock

6.200USD+29.17%Mkt Cap: 4.77M $P/E:

Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and in…

Key Statistics

Company
Market Cap4.77M $
Enterprise Value4.21M $
Revenue (TTM)64.69K $
Gross Profit17.57K $
Net Income (TTM)-8.64M $
Revenue/Share0.1300 USD
Last Price6.200 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees5
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)86.17
PEG
EV/EBITDA
EV/Revenue65.05
P/S61.54
P/B-0.90
EPS (TTM)-20.14
EPS (Forward)0.06
52W Range
4.5601% of range138.00
52W High138.00 USD
52W Low4.560 USD
Profitability
Gross Margin80.59%
Oper. Margin-11313.45%
EBITDA Margin0.00%
Profit Margin-39662.77%
ROE471.92%
ROA-155.37%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-5.41M $
CapEx (TTM)
FCF Margin-5106.33%
FCF Yield-69.19%
Net Debt227.20K $
Net Debt/EBITDA
Balance Sheet
Debt/Equity-2.90
Current Ratio0.66
Quick Ratio0.40
Book Value/Sh-5.7540 USD
Cash/Share1.976 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Splits
Last Split1:75
Split DateAug 7, 2026
Analyst Consensus
Rating
Target (Mean)
Target Range
# Analysts
Ownership
Shares Out.770.08K
Float477.67K
Insiders31.65%
Institutions3.85%
Short Interest
Short Ratio0.0d
Short % Float0.48%
Short % Out.0.36%
Shares Short2.74K
Short (prev mo.)12.52K
Technical
SMA 5011.95 (-48.1%)
SMA 20041.60 (-85.1%)
Beta
S&P 52W Chg18.16%
Avg Vol (30d)1.95M
Avg Vol (10d)67.97K
Technical Indicators
RSI (14)39.9
MACD-1.9013
MACD Signal-2.2754
MACD Hist.+0.3741
BB Upper8.632 USD
BB Middle6.114 USD
BB Lower3.596 USD
BB Width82.36%
ATR (14)1.517 USD
Vol Ratio (20d)740.10x